Tech Company Financing Transactions
Kincell Bio Funding Round
Kincell Bio closed a $22 million financing round on 5/15/2025. Backers included NewSpring Capital and Kineticos Ventures.
Transaction Overview
Company Name
Announced On
5/15/2025
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Undisclosed
Investors
NewSpring Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its expansion of its cGMP capabilities, enhance its process development services, and support the development of solutions used to emerging cell therapy companies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1622 North West 55th Place
Gainesville, FL 32653
USA
Gainesville, FL 32653
USA
Phone
Undisclosed
Website
Email Address
Overview
Kincell Bio leverages extensive scientific expertise and industry knowledge to partner with cell therapy innovators. Our core values of transparency, accountability, and accuracy are at the heart of what makes us a trusted partner for process and analytical development, CMC support, and high-quality clinical cell therapy manufacturing services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Shailesh Maingi
Chief Executive Officer
Bruce Thompson
Browse more venture capital transactions:
Prev: 5/15/2025: Sproutr venture capital transaction
Next: 5/15/2025: Sprinter Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs